(1 - 8 von 9
)
Press Release : Immatics Presents Data Update on Dose Escalationwww.marketscreener.com › ... › News
www.marketscreener.com
· Cedrik Britten, M.D., Chief Medical Officer at Immatics added: "The clinical data emerging from this early phase of our ACTengine(R) trials ...
Immatics Presents Data Update on Dose Escalation from ...
www.wallstreet-online.de
· Cedrik Britten, M.D., Chief Medical Officer at Immatics added: “The clinical data emerging from this early phase of our ACTengine trials provides a first evidence of anti-tumor activity at dose...
sortiert nach Relevanz / Datum